For its dedication to providing outstanding oncology care to the community, the Riverside Cancer Institute has been recognized as a “Great Oncology Program” by Becker’s Hospital Review, a leading source of healthcare news and information. Becker’s releases its list of hospitals and health systems with leading oncology programs annually.
“It is an honor to be recognized by Becker’s for the outstanding care the Riverside Cancer Institute provides,” said Riverside President and CEO Phil Kambic, “Ensuring our community has access to the latest in cancer treatment technology is a priority, and we are proud to bring our patients complete cancer care close to home.”
Earlier this fall, Riverside added a second TrueBeam linear accelerator, the region’s most advanced cancer treatment technology. TrueBeam delivers high-energy radiation to cancerous tumors with improved accuracy, minimizing damage to healthy tissue. The TrueBeam also can perform non-invasive, stereotactic radio-surgery for lung and brain tumors – a very precise form of radiation that targets tumors in difficult-to-reach locations.
Additionally, patients at the Riverside Cancer Institute have access to a full continuum of care, including oncologists and nurse practitioners, social workers, dieticians, physical therapists, nurse navigators, pharmacists, financial counselors, authorization team members, and pastoral care chaplains.
“Our team is dedicated to providing patients the best possible care throughout their journey,” said Kirstin Carson, director of Oncology and Infusion Services. “I am so proud of my team for everything they do for our patients and receiving this recognition from Becker’s is truly an honor.”